A recent study that found there has been a massive increase in type 2 diabetes cases worldwide since 1990 is an indication ...

Ministers have been urged to ditch "gimmicks and soundbites" while addressing the soaring cost of obesity to the NHS.

Metsera has brought in over $500m in funding in just seven months as it looks to enter the competitive weight loss arena.

Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.

Why is bulldozer justice relevant to the UPSC Exam? What significance do topics like the weight-loss drug Semaglutide, the ...

A new study has revealed that GLP-1 drugs, commonly used for diabetes and weight loss, show promise in treating alcohol ...

Ro details dietary choices that may help Wegovy's capacity to regulate appetite and foster a healthier weight as well as ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of the active ingredient in those medications have now been linked to at least ...

Weight-loss drugs Ozempic and Wegovy have become popular worldwide. Many people have also reported suffering some serious ...

Diabetes is part of 11.8% of GP consultations. Following new research and a period of intense interest pharmacological weight management options, including agents such as semaglutide, and the ...

As a new study finds that people who stopped taking semaglutide, the active ingredient in the new blockbuster weight loss ...